Institutional Capital & Cannabis (IC3) Europe
Frankfurt, Germany
February 24, 2020

Description

IMN and Prohibition Partners are excited to host their next cannabis investment conference in Europe’s largest potential market for cannabis – Germany.  As Europe’s largest economy, Germany has quickly become the leader for medicinal cannabis demand.  Prohibition Partners estimates the German medicinal market will be worth more than €1 billion by the end of 2020.  The country completed a tender process this year that awarded medicinal cultivation licenses to three companies, although the first large-scale harvest in late 2020 is not expected to meet demand, meaning imports from Europe and North America will maintain a key role.
 
The IC3 conferences are a meeting place for investors who wish to deploy capital or learn more about this exciting and high-growth new asset class, cannabis companies and investment funds who are looking to raise money or showcase their products, and professional service providers who facilitate these groups doing business.
 
Our US conference have earned a reputation for delivering quality content, expert speakers and a high showing of asset allocators and institutional investors.  Recent programs have featured speakers from leading cannabis companies iAnthus, Columbia Care, Tilray, MedMen along with funds such as Poseidon, Merida, Tuatara, Gotham Green Partners and Casa Verde, to name just a few.
 
IC3 Frankfurt will bring together North American and European brands, operators, investors, financial institutions, industry groups, politicians and other professional service providers who are establishing Europe’s legal cannabis markets.  We hope you are able to join us.
 

Conference Highlights

Networking Tutorial

    Platform Introduction

    LOADING MEDIA...

    Getting Started

    LOADING MEDIA...

    Updating Personal Info

    LOADING MEDIA...

    Updating Demographics

    LOADING MEDIA...

    Searching By Name/Company

    LOADING MEDIA...

    Filter By Demographics

    LOADING MEDIA...

    Send Invitation

    LOADING MEDIA...

    Accept Invitation

    LOADING MEDIA...

    Messaging Connections

    LOADING MEDIA...

    Post Conference Content

    LOADING MEDIA...

My Agenda

  • To view your agenda you must be signed in Sign-In

Agenda

    Monday, February 24th, 2020

      8:00 AM
      Registration & Breakfast



      8:45 AM
      Chairperson’s Opening Remarks



      8:50 AM
      Global State of the Industry and Market Outlook

      • In the last year we have seen considerable progress across the globe in the move towards cannabis legalisation, with the introduction of legislation in a number of US states and countries in Europe, Africa, and Asia.  This session will look at the numbers, highlighting the most promising growth markets in Europe and abroad.

      9:20 AM
      Investment Opportunities in Legal Cannabis

      • There are a number of investment sectors in the cannabis industry that attract attention from various capital vehicles.  Each sector is different from the other and has unique opportunities and challenges associated with it.  This opening panel will discuss how opportunities are evolving across these sectors and what investors should consider when making decisions. 

        • Rod Stephan, Partner (Altitude Investment Management)

      10:00 AM
      Deep Dive into Progress in Germany

      • As Europe’s largest economy, Germany has quickly become the leader for medicinal cannabis demand.  Prohibition Partners estimates the German medicinal market will be worth more than €1 billion the end of 2020.  The country completed a tender process this year that awarded medicinal cultivation licenses to three companies, although the first large-scale harvest in late 2020 is not expected to meet demand, meaning imports from Europe and North America will maintain a key role.

        • Kai-Friedrich Niermann, Founder (KFN+)
        • Burkhard Blienert, Former MP (SPD) (German Bundestag)
        • Benedikt Sons, Co-Founder and CEO (Cansativa GmbH)

      10:40 AM
      Networking Break



      11:25 AM
      Update on the Regulatory Landscape in Europe

      • Significant legislative events in Europe were witnessed by the sector last year.  The UK legalized the limited prescribed use of medical cannabis products and Germany has issued more tenders for domestic medical cannabis production.  Despite this, considerable issues with access remain.   This unique panel will examine the legislative and regulatory status of medical and recreational cannabis across Europe, how these laws and regulations are being implemented, and what the major stumbling blocks are when setting up such frameworks. 

        • Stephen Murphy, Co-Founder & Group Managing Director (NOBL)
        • Ana Afuera, ENCOD Executive Committee (European Coalition for Just and Effective Drug Policies)
        • Jens Kramer, VP Europe Operations (Avicanna Inc)

      12:05 PM
      Shaping the Legal Cannabis Market Through Innovation

      • Innovation is crucial to the growth of any industry and the same can be said for the cannabis sector.  This panel will discuss where the market is going in terms of R&D, technological and scientific advancements and other operational solutions that are moving the industry forward.

      12:45 PM
      Lunch



      1:45 PM
      Money-making Opportunities in Ancillary Businesses

      • There are a plethora of value-add opportunities for non-plant touching businesses looking to service the nascent cannabis industry and each of these opportunities has its own associated challenges.  These panelists make the case for why investing in ancillary businesses will provide the best returns and how these challenges can be overcome.

      2:25 PM
      Impact Investing: Medical Efficacy and Societal Impact of Legal Cannabis

      • More and more investors are looking to have an impact investing allocation in their portfolio.  Social justice, regulatory reform and improving the overall health of our society make cannabis a prime fit for this allocation.  This panel will address the socioeconomic benefits that a well-regulated cannabis industry can offer.

        • Jacqueline Bennett, Director (Sands Lane Capital)

      3:05 PM
      Networking Break



      3:30 PM
      From Theory to Reality: Invest Like the Best

      • We hear from experienced investors and finance professionals who are already active in this exciting new asset class.  Our panelists reveal firsthand accounts of where they've found success, hard lessons learned and pitfalls to be avoided, and key nuggets of advice they have for those considering investing in this space.

        • Will Muecke, Managing Member (Artemis Growth Partners)
        • Brian Sheng, CEO (Asia Horizon Group)

      4:10 PM
      Crystal Balling the Future of Cannabis in Europe

      • After a full, solid day of discussion, where does this leave us?  What has surprised us in the past year and what can we expect for the months and years ahead?  Industry leaders from business and policy discuss legalisation, regulation and what this means for all of you.

      5:00 PM
      Keynote Fireside Chat



      5:20 PM
      Networking Reception



      6:20 PM
      Conference Concludes



Sponsors

Register

This is a past conference, no registration is available.

Our Partners

Contact Us

Venue

  • Conference Venue
  • Hilton Frankfurt City Centre


    Hochstrasse 4, 60313
    Frankfurt,
    Germany
    Fax: 49 69 133820

Speakers

Content/Audio Files

  • Only sessions that contain published presentations or audio files are shown here. To view full agenda please expand "Agenda" tab.

    Also please do not forget that if you are playing audio files on the mobile device (without being connected to WiFi), your Mobile/Cellural Internet data will be spent to play these audio files.
  • Monday, February 24th, 2020

1120 Avenue of the Americas, 6th Floor, New York, NY 10036
Tel: +1(212)901-0506 Fax: +1(212)768-2484
Email: mail@imn.org


View Full Site
You need to login before accessing this section. Click "Login" from bottom menu.

Please sign in

Create Account Recover Password Sign in with LinkedIn

Enter Your Email: